Buy Navidea Biopharma Stock | NAVB Stock Price & Latest News | Public
NAVB

Navidea Biopharma

$0.00 (0.00%)Today
    Small Market Cap

    About NAVB

    Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is hea...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.04
    -0.09
    -0.13
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.12

    Actual EPS
    Q4 2020

    Stats

    Market Cap$64,04M
    Volume2,74k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$5.36
    1 Year Low$0.63
    Open$2.37
    High$2.41
    Low$2.35

    Buy any stock with any amount of money.

    Download the App
    Download the app